Catenaa, Sunday, July 20, 2025- Nasdaq-listed BioSig Technologies has secured up to $1.1 billion in financing to support its plan to tokenize the global commodities market and launch a gold-backed treasury, following its merger with Bahamas-based Streamex Exchange Corporation.
The funding package includes $100 million in senior secured convertible debentures and a $1 billion equity line of credit, according to a company press release.
The debentures carry a 4% annual interest rate, rising to 18% if BioSig defaults, and are convertible into common stock.
The equity line allows BioSig to sell shares to the institutional investor over 36 months.
The first $75 million tranche of debentures and equity line activation are expected to close Oct. 7, pending shareholder approval and customary regulatory conditions. The second $25 million tranche will follow after meeting additional requirements. The placement was co-led by Tether custodian Cantor Fitzgerald and Clear Street.
The merger with Streamex marked a strategic pivot for BioSig from medical devices to real-world asset tokenization. Streamex specializes in onchain commodities like gold, aiming to expand market access and liquidity.
CEO Henry McPhie emphasized the company’s goal to unlock transparency and accessibility in the $142 trillion commodities market.
BioSig and Streamex plan to roll out a gold-backed treasury management strategy funded by this capital raise. The move aligns with a broader global shift toward tokenization, a market Ripple estimates will grow from $12.8 billion to nearly $19 trillion by 2033.
Shares of BioSig jumped over 10% Monday and gained more than 22% in Tuesday’s pre-market trading.
